Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling.
about
Analysing calcium signalling of cells under high shear flows using discontinuous dielectrophoresis.Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 ReceptorsFacilitation of TRPV4 by TRPV1 is required for itch transmission in some sensory neuron populationsExamination of the role of transient receptor potential vanilloid type 4 in endothelial responses to shear forces.Transient receptor potential (TRP) channels in the airway: role in airway disease.Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivoTRPV4 as a therapeutic target for joint diseases.Shear stress mediates exocytosis of functional TRPV4 channels in endothelial cells.Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig.Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain stateEffects of Food Components That Activate TRPA1 Receptors on Mucosal Ion Transport in the Mouse Intestine.Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells.Yiqi Huayu recipe relieves nerve root constriction induced radicular neuralgia by down-regulating TRPV4 expression in dorsal root ganglion.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactProtease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.Calcium-permeable ion channels in pain signaling.Targeting TRP channels for chronic cough: from bench to bedside.Protease-activated receptors and itch.MLC1 protein: a likely link between leukodystrophies and brain channelopathies.G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease.Proteinases, Their Extracellular Targets, and Inflammatory Signaling.Activation of TRPV1 mediates thymic stromal lymphopoietin release via the Ca2+/NFAT pathway in airway epithelial cells.Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature.Concurrent shear stress and chemical stimulation of mechano-sensitive cells by discontinuous dielectrophoresis.TRPV4 activates autonomic and behavioural warmth-defence responses in Wistar rats.Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception.Protease-activated receptors as therapeutic targets in visceral pain.Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission.A 340/380 nm light-emitting diode illuminator for Fura-2 AM ratiometric Ca2+ imaging of live cells with better than 5 nM precision.Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase.Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A-mediated phosphorylation.A Nonsteroidal Novel Formulation Targeting Inflammatory and Pruritus-Related Mediators Modulates Experimental Allergic Contact Dermatitis.
P2860
Q27308820-6B3E3529-ED77-4A7A-88F7-6FE1689070EAQ28552751-4100ADB8-EF85-4C06-8502-C83BACF96F81Q28816919-88679CB8-9C01-45B5-993A-064FA048FBB4Q30590041-4B3CD861-EB72-4FC2-B116-727B8DF2DFB8Q33562184-AAD383DA-DD8B-4841-B917-DB9D61F3E072Q34025076-F8F96CF3-A4AB-4F7F-B03D-49E39DDE2CB8Q34025103-93877D65-14F2-4FC7-B7B4-11C679F84E63Q35181627-66574992-03F2-457D-82E2-2A80AA0E2D13Q35750599-91B8CB53-861F-4F63-ACFB-E91335A4B191Q36065514-E4708EA4-EC98-4ABC-9D08-CBB8DAAF22B3Q36108394-8B97334A-0544-4CD6-A176-044DB074A478Q36162256-023FBB10-DCBB-4A0A-9145-B8C8EBC8EEFCQ36322931-18EEFF86-8D36-4A61-A029-0EEFD1EC095BQ36323532-22FFB77D-94FB-4EA3-A606-2B8853501F9FQ36411899-E245F733-5AA0-4ED6-A517-BAF1DC39704BQ37348262-A534B238-C585-4451-AEBC-0DCE3C37C815Q37675807-46C9533F-CD2A-43C8-AFF7-D6289F75592FQ38126397-ECCAC119-4962-4D2E-AB5F-945926051588Q38175134-14EAC74A-56BB-4E18-930E-8A074B5444ABQ38311862-CD0DC844-3DDA-4B37-AE45-7C0FAB963E23Q38415128-3E85FC20-11D5-4E2E-9974-A64F61C1707EQ38425447-119E8E09-EBDA-450F-B1BE-51D8C19A3A24Q38892537-EA6ADE76-3FF1-4E23-9144-4AFB1EF729E9Q38966192-0793D007-FF63-42B9-B002-7B9D97B27F63Q38984517-1CF8F41A-EA77-42B4-BE68-C87CF0538E38Q39154920-641B168C-C056-4061-8405-DD6A9910FDF8Q39959829-C25DE1A8-5FB2-4BBD-84F9-5AC8E8A3A8B7Q40000771-8A2F385C-9339-49D8-AD8D-580C22286F7DQ41295546-4B9489DE-69DE-413B-AC55-B04259FE0BDEQ41298460-52595B1C-CAB2-466D-9F7B-3A7D56B79828Q41341638-24D94C0F-CDD0-46EB-A6E2-150846E9B115Q41635414-8116ADE2-CD93-4C81-9DF1-7E590A971A7FQ42339322-9175BF72-9281-412C-9A1D-2456DB01364BQ42849011-6F075E9D-B27E-499F-BE40-5FD6718B3AC3Q42915550-429F92A8-D795-4F0B-A3F2-5D108C73EA77Q46800669-94E191B6-8281-4023-9E65-5C8CC9790BF1Q48181823-DD49E5B6-D519-4BE0-9BD5-8519956F6F18Q48600823-F0E4E0D9-0184-45EF-B647-F740577B3338Q49806546-4C8FD2DF-00BF-415B-BBB4-B41F4E2DB76FQ49911009-0AEEA129-9245-4555-9324-17C34BB4E631
P2860
Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Protease-activated receptor 2 ...... tained inflammatory signaling.
@ast
Protease-activated receptor 2 ...... tained inflammatory signaling.
@en
type
label
Protease-activated receptor 2 ...... tained inflammatory signaling.
@ast
Protease-activated receptor 2 ...... tained inflammatory signaling.
@en
prefLabel
Protease-activated receptor 2 ...... tained inflammatory signaling.
@ast
Protease-activated receptor 2 ...... tained inflammatory signaling.
@en
P2093
P2860
P50
P356
P1476
Protease-activated receptor 2 ...... stained inflammatory signaling
@en
P2093
Fe C Abogadie
Nigel W Bunnett
Silvia Amadesi
TinaMarie Lieu
William Darby
Wolfgang Liedtke
P2860
P304
P356
10.1074/JBC.M112.438184
P407
P577
2013-01-03T00:00:00Z